Market revenue in 2023 | USD 536.8 million |
Market revenue in 2030 | USD 944.4 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Ultrasound |
Fastest growing segment | PAMG-1 Immunoassay |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pelvic exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN) |
Key market players worldwide | Qiagen NV, Hologic Inc, CooperSurgical, Abbott Laboratories, Biosynex, Sera Prognostics, Medix Biochemica, Clinical Innovations, NX Prenatal, IQ Products |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preterm birth and prom testing market will help companies and investors design strategic landscapes.
Ultrasound was the largest segment with a revenue share of 31.82% in 2023. Horizon Databook has segmented the North America preterm birth and prom testing market based on pelvic exam, ultrasound, biochemical markers, uterine monitoring, nitazine test, ferning test, pooling, pamg-1 immunoassay, igfbp test, fetal fibronectin (ffn) covering the revenue growth of each sub-segment from 2018 to 2030.
In 2020, North America held the largest market share due to high prevalence of preterm births in the region. Changes in life style factors such as excessive alcohol consumption and sedentary lifestyles are also contributing to the increase in number of premature births in the U.S.
Various awareness campaigns and initiatives being undertaken by nonprofit organizations in both the U.S. and Canada are expected to address challenges faced by premature babies and their families. For instance, in 2017, the March of Dimes organized the Prematurity Campaign Collaborative with an aim to address rising preterm birth rates and persistent health inequities in the U.S.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America preterm birth and prom testing market , including forecasts for subscribers. This continent databook contains high-level insights into North America preterm birth and prom testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account